$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-08-10 AccNo: 0001193125-17-253562 Size: 113 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接